Targeted Medical Pharma, Inc. (TRGM) 股价，以美元计价

Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a publicly traded, Los Angeles-based biotechnology company that develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary amino acid based medical foods, and recently launched its first dietary supplement, Clearwayz. The products are sold directly to physicians, pharmacies and patients in the United States. The company is currently developing amino acid based therapies designed for the oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I. Targeted Medical Pharma and its' subsidiary companies, Complete Claims Processing and Physician Therapeutics, provide healthcare practitioners and patients with clinically proven therapies required to safely and effectively manage disease without harmful side effects. We are committed to delivering long-term value to investors by maintaining disciplined cost controls, optimizing capital investment and adhering to the highest standards of corporate governance.